177 related articles for article (PubMed ID: 33154639)
21. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia.
Wang T; Hu Y; Leach MK; Zhang L; Yang W; Jiang L; Feng ZQ; He N
Int J Pharm; 2012 Jan; 422(1-2):462-71. PubMed ID: 22101293
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia.
Zhu L; Bai X; Wang S; Hu Y; Wang T; Qian L; Jiang L
Neonatology; 2014; 106(2):143-8. PubMed ID: 24969821
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.
Hellewell SC; Yan EB; Alwis DS; Bye N; Morganti-Kossmann MC
J Neuroinflammation; 2013 Dec; 10():156. PubMed ID: 24344874
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4.
Chu H; Ding H; Tang Y; Dong Q
Lab Invest; 2014 Sep; 94(9):1042-53. PubMed ID: 24978642
[TBL] [Abstract][Full Text] [Related]
27. Biological characterization of recombinant human erythropoietin.
Krumwieh D; Arnold I; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
[TBL] [Abstract][Full Text] [Related]
28. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
29. Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury.
Wang B; Kang M; Marchese M; Rodriguez E; Lu W; Li X; Maeda Y; Dowling P
Neurotherapeutics; 2016 Apr; 13(2):418-27. PubMed ID: 26715414
[TBL] [Abstract][Full Text] [Related]
30. Novel erythropoietin-loaded nanoparticles with prolonged in vivo response.
Fayed BE; Tawfik AF; Yassin AE
J Microencapsul; 2012; 29(7):650-6. PubMed ID: 22533485
[TBL] [Abstract][Full Text] [Related]
31. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
Marmarou CR; Liang X; Abidi NH; Parveen S; Taya K; Henderson SC; Young HF; Filippidis AS; Baumgarten CM
Brain Res; 2014 Sep; 1581():89-102. PubMed ID: 24933327
[TBL] [Abstract][Full Text] [Related]
32. Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats.
Jiang H; Li H; Cao Y; Zhang R; Zhou L; Zhou Y; Zeng X; Wu J; Wu D; Wu D; Guo X; Li X; Wu H; Li P
Brain Res; 2021 Oct; 1768():147586. PubMed ID: 34289379
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial.
Li ZM; Xiao YL; Zhu JX; Geng FY; Guo CJ; Chong ZL; Wang LX
Clin Neurol Neurosurg; 2016 Nov; 150():80-83. PubMed ID: 27611985
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage.
Grasso G; Graziano F; Sfacteria A; Carletti F; Meli F; Maugeri R; Passalacqua M; Certo F; Fazio M; Buemi M; Iacopino DG
Neurosurgery; 2009 Oct; 65(4):763-9; discussion 769-70. PubMed ID: 19834382
[TBL] [Abstract][Full Text] [Related]
35. Hypertonic Saline Alleviates Brain Edema After Traumatic Brain Injury via Downregulation of Aquaporin 4 in Rats.
Yin J; Zhang H; Chen H; Lv Q; Jin X
Med Sci Monit; 2018 Mar; 24():1863-1870. PubMed ID: 29600800
[TBL] [Abstract][Full Text] [Related]
36. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats.
Guo Q; Sayeed I; Baronne LM; Hoffman SW; Guennoun R; Stein DG
Exp Neurol; 2006 Apr; 198(2):469-78. PubMed ID: 16445913
[TBL] [Abstract][Full Text] [Related]
37. Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.
Khairallah MI; Kassem LA; Yassin NA; Gamal el Din MA; Zekri M; Attia M
Brain Res Bull; 2016 Mar; 121():148-57. PubMed ID: 26802509
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin protects newborn rat against sevoflurane-induced neurotoxicity.
Pellegrini L; Bennis Y; Velly L; Grandvuillemin I; Pisano P; Bruder N; Guillet B
Paediatr Anaesth; 2014 Jul; 24(7):749-59. PubMed ID: 24725211
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage.
Lee ST; Chu K; Sinn DI; Jung KH; Kim EH; Kim SJ; Kim JM; Ko SY; Kim M; Roh JK
J Neurochem; 2006 Mar; 96(6):1728-39. PubMed ID: 16539688
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin-mediated activation of aquaporin-4 channel for the treatment of experimental hydrocephalus.
Rizwan Siddiqui M; Attar F; Mohanty V; Kim KS; Shekhar Mayanil C; Tomita T
Childs Nerv Syst; 2018 Nov; 34(11):2195-2202. PubMed ID: 29982881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
